Analyst Price Target is $6.60
▲ +76.47% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for OncoCyte in the last 3 months. The average price target is $6.60, with a high forecast of $11.00 and a low forecast of $4.00. The average price target represents a 76.47% upside from the last price of $3.74.
Current Consensus is
The current consensus among 5 contributing investment analysts is to buy stock in OncoCyte. This Buy consensus rating has held steady for over two years.